Pureos Bioventures is a venture capital fund, which invests exclusively in private innovative drug development companies, with a special emphasis on the next generation of biological drugs and drug formats. The fund’s portfolio companies are built on scientific excellence to develop therapies across a broad indication spectrum including oncology, immunology, ophthalmology, rare diseases, and
neuroscience. Pureos has built a team with deep investment, operating and clinical expertise, that strives to impact patients’ lives by advancing innovative treatments for devastating diseases.
Company Details
- Employees
- 14
- Address
- Churerstrasse 47, Pfäffikon,schwyz 8808,switzerland
- Industry
- Venture Capital And Private Equity Principals
- NAICS
-
Miscellaneous Intermediation
- Website
- http://www.pureosbio.com
- Keywords
- Hellerup.
- HQ
- Pfäffikon, Schwyz
Pureos Bioventures Questions
Pureos Bioventures's website is http://www.pureosbio.com
Pureos Bioventures's LinkedIn profile is https://ch.linkedin.com/company/pureos-bioventures
Pureos Bioventures has
14 employees.
View email and phone details for 14
employees at Pureos Bioventures.
Pureos Bioventures's industry is
Venture Capital and Private Equity Principals
Pureos Bioventures's top competitors are
Bb Biotech,
Araris Biotech Ag,
Mediar Therapeutics,
Novo Holdings,
Clavystbio,
Vi Partners,
Sound Bioventures,
Frazier Life Sciences,
Omega Funds,
Alentis Therapeutics.
Pureos Bioventures's categories are Venture Capital and Private Equity Principals
